BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4083636)

  • 21. Treatment of pituitary macroadenomas secreting PRL, HGH or ACTH with long-acting bromocriptine.
    Halperin I; Rodriguez MD; Cardenal C; Casamitjana R; Martinez Osaba MJ; Lienas V; Vilardell E
    J Endocrinol Invest; 1987 Jun; 10(3):277-82. PubMed ID: 3040850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bromocriptine induced cystic tumour regression in advanced prolactinomas (author's transl)].
    Galvan G; Frick J; Irnberger T
    Dtsch Med Wochenschr; 1981 May; 106(20):637-42. PubMed ID: 7227210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of patients with prolactinomas.
    Werder Kv; Fahlbusch R; Landgraf R; Pickardt CR; Rjosk HK; Scriba PC
    J Endocrinol Invest; 1978 Jan; 1(1):47-58. PubMed ID: 755842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction in size of a pituitary tumor by bromocriptine therapy.
    McGregor AM; Scanlon MF; Hall K; Cook DB; Hall R
    N Engl J Med; 1979 Feb; 300(6):291-3. PubMed ID: 759882
    [No Abstract]   [Full Text] [Related]  

  • 25. [Alteration of prolactin secretion after transsphenoidal adenomectomy for prolactinomas].
    Yokoyama M
    No To Shinkei; 1990 Aug; 42(8):773-9. PubMed ID: 2223270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study.
    Molitch ME; Elton RL; Blackwell RE; Caldwell B; Chang RJ; Jaffe R; Joplin G; Robbins RJ; Tyson J; Thorner MO
    J Clin Endocrinol Metab; 1985 Apr; 60(4):698-705. PubMed ID: 3882737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging of tumours of the sellar region. Evaluation of treatment with bromocriptine retard.
    Lundberg PO; Bergström K; Thuomas KA; Muhr C; Enoksson P
    Acta Radiol Suppl; 1986; 369():310-3. PubMed ID: 2980483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Histological changes and operative findings of pituitary adenomas after bromocriptine treatment].
    Takahashi T; Kuwayama A; Katoh T; Kageyama N
    Nihon Naibunpi Gakkai Zasshi; 1986 Dec; 62(12):1336-51. PubMed ID: 3817228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bromocriptine treatment of hyperprolactinemia].
    Gauer J; Heberling HJ; Stubert B; Richardt W; Lohmann D
    Z Gesamte Inn Med; 1985 Jul; 40(13):393-6. PubMed ID: 4036221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect rates of different modalities for treatment of prolactin adenomas.
    Wollesen F; Bendsen BB
    Am J Med; 1985 Jan; 78(1):114-22. PubMed ID: 3881020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-lasting suppression of prolactin secretion and rapid shrinkage of prolactinomas after a long-acting, injectable form of bromocriptine.
    Montini M; Pagani G; Gianola D; Pagani MD; Salmoiraghi M; Ferrari L; Lancranjan I
    J Clin Endocrinol Metab; 1986 Jul; 63(1):266-8. PubMed ID: 3711262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bromocriptine treatment of prolactinomas.
    von Werder K; Eversmann T; Fahlbusch R; Rjosk HK
    N Engl J Med; 1979 Jun; 300(24):1391-2. PubMed ID: 440368
    [No Abstract]   [Full Text] [Related]  

  • 33. Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural, and morphometric study.
    Tindall GT; Kovacs K; Horvath E; Thorner MO
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1178-83. PubMed ID: 6752167
    [No Abstract]   [Full Text] [Related]  

  • 34. Bromocriptine treatment of prolactinomas.
    Bergh T; Nillius SJ; Lundberg PO; Wide L
    N Engl J Med; 1979 Jun; 300(24):1391. PubMed ID: 440367
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antitumor effect of bromocriptine in 5 cases of invasive prolactinoma].
    Guibout M; Jaquet P; Grisoli F; Tapias PL; Mouly A
    Ann Med Interne (Paris); 1982; 133(1):48-50. PubMed ID: 7065589
    [No Abstract]   [Full Text] [Related]  

  • 36. Bromocriptine treatment of prolactinomas.
    McGregor AM; Hall K; Scanlon MF; Hall R
    N Engl J Med; 1979 Jun; 300(24):1392. PubMed ID: 440369
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anti-tumorous effect of bromocriptine in prolactin-secreting adenomas. A case-report (author's transl)].
    Bigorgne JC; Rohmer V; Mercier P; Galland F
    Sem Hop; 1982 Mar; 58(11):679-82. PubMed ID: 6278614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spontaneous sparsely-granulated prolactin-producing pituitary adenomas in aging rats. A prospective study of the effect of bromocriptine.
    McComb DJ; Hellmann P; Kovacs K; Scott D; Evans WS; Burdman JA; Thorner MO
    Neuroendocrinology; 1985 Sep; 41(3):201-11. PubMed ID: 4047338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid regression of pituitary tumours during bromocriptine treatment of women with hyperprolactinaemia.
    Bergh T; Nillius SJ; Lundberg PO; Moström U; Enoksson P; Ohman L; Wide L
    Ups J Med Sci; 1982; 87(3):259-67. PubMed ID: 7157557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results of medical and surgical treatment in 3 cases of prolactin-secreting pituitary adenoma].
    Abate F; Oliva A; Baviera G; La Malfa L; Barresi M
    Minerva Ginecol; 1982 Dec; 34(12):1039-45. PubMed ID: 7155436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.